Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1076825

Cover Image

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1076825

Cell & Gene Therapy Manufacturing Services Market Research Report by Type, Indication, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4949
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF, Excel & Online Access - 1 Year (Site License)
USD 7949
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 9949

Add to Cart

The Global Cell & Gene Therapy Manufacturing Services Market size was estimated at USD 12.77 billion in 2021 and expected to reach USD 14.69 billion in 2022, and is projected to grow at a CAGR 15.32% to reach USD 30.04 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Cell & Gene Therapy Manufacturing Services to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Cell Therapy and Gene Therapy. The Cell Therapy is further studied across Allogeneic, Autologous, and Viral Vector. The Allogeneic is further studied across Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Natural Killer Cells, and T-cells. The Autologous is further studied across Hematopoietic Stem Cells, Mesenchymal Stem Cells, Natural Killer Cells, and T-cells. The Viral Vector is further studied across Adeno-associated Virus Vectors and Retroviral Vectors. The Gene Therapy is further studied across Non-viral Vector and Oligonucleotides.

Based on Indication, the market was studied across Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases, Oncology Diseases, Ophthalmology Diseases, and Orthopedic Diseases.

Based on Application, the market was studied across Clinical Manufacturing and Commercial Manufacturing.

Based on End-User, the market was studied across Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell & Gene Therapy Manufacturing Services market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell & Gene Therapy Manufacturing Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell & Gene Therapy Manufacturing Services Market, including bluebird bio, Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., Cell and Gene Therapy Catapult, Charles River Laboratories International, Inc., DENARASE, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, Innovative Cellular Therapeutics Co., Ltd., Lonza Group, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Nikon CeLL innovation Co., Ltd., Nikon Corporation, Novartis AG, Oxford Biomedica plc, Takara Bio Inc., Thermo Fisher Scientific, and WuXi AppTec.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Cell & Gene Therapy Manufacturing Services Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell & Gene Therapy Manufacturing Services Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell & Gene Therapy Manufacturing Services Market?
  • 4. What is the competitive strategic window for opportunities in the Global Cell & Gene Therapy Manufacturing Services Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Cell & Gene Therapy Manufacturing Services Market?
  • 6. What is the market share of the leading vendors in the Global Cell & Gene Therapy Manufacturing Services Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Cell & Gene Therapy Manufacturing Services Market?
Product Code: MRR-BB6269D14168

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High incidence of cancer and other target diseases
      • 5.1.1.2. Increasing investments in pharmaceutical R&D and advanced technologies by CDMOs
      • 5.1.1.3. Rapidly growing incidence of cancer and other target diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High operational costs associated with cell & gene therapy manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for cell & gene therapies globally
      • 5.1.3.2. Increasing number of cell & gene therapy clinical trials
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of mutagenesis and other unwanted outcomes
  • 5.2. Cumulative Impact of COVID-19

6. Cell & Gene Therapy Manufacturing Services Market, by Type

  • 6.1. Introduction
  • 6.2. Cell Therapy
    • 6.2.1. Allogeneic
      • 6.2.1.1. Hematopoietic Stem Cells
      • 6.2.1.2. Induced Pluripotent Stem Cells
      • 6.2.1.3. Mesenchymal Stem Cells
      • 6.2.1.4. Natural Killer Cells
      • 6.2.1.5. T-cells
    • 6.2.2. Autologous
      • 6.2.2.1. Hematopoietic Stem Cells
      • 6.2.2.2. Mesenchymal Stem Cells
      • 6.2.2.3. Natural Killer Cells
      • 6.2.2.4. T-cells
    • 6.2.3. Viral Vector
      • 6.2.3.1. Adeno-associated Virus Vectors
      • 6.2.3.2. Retroviral Vectors
  • 6.3. Gene Therapy
    • 6.3.1. Non-viral Vector
    • 6.3.2. Oligonucleotides

7. Cell & Gene Therapy Manufacturing Services Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiovascular Diseases
  • 7.3. Central Nervous System Disorders
  • 7.4. Infectious Diseases
  • 7.5. Oncology Diseases
  • 7.6. Ophthalmology Diseases
  • 7.7. Orthopedic Diseases

8. Cell & Gene Therapy Manufacturing Services Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Manufacturing
  • 8.3. Commercial Manufacturing

9. Cell & Gene Therapy Manufacturing Services Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Pharmaceutical & Biotechnology Companies

10. Americas Cell & Gene Therapy Manufacturing Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa Cell & Gene Therapy Manufacturing Services Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. bluebird bio, Inc.
  • 14.2. Boehringer Ingelheim International GmbH
  • 14.3. Catalent, Inc.
  • 14.4. Cell and Gene Therapy Catapult
  • 14.5. Charles River Laboratories International, Inc.
  • 14.6. DENARASE
  • 14.7. F. Hoffmann-La Roche Ltd.
  • 14.8. FUJIFILM Holdings Corporation
  • 14.9. Innovative Cellular Therapeutics Co., Ltd.
  • 14.10. Lonza Group
  • 14.11. Merck KGaA
  • 14.12. Miltenyi Biotec B.V. & Co. KG
  • 14.13. Nikon CeLL innovation Co., Ltd.
  • 14.14. Nikon Corporation
  • 14.15. Novartis AG
  • 14.16. Oxford Biomedica plc
  • 14.17. Takara Bio Inc.
  • 14.18. Thermo Fisher Scientific
  • 14.19. WuXi AppTec

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
Product Code: MRR-BB6269D14168

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: DYNAMICS
  • FIGURE 2. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2027
  • FIGURE 5. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, 2019-2027 (USD BILLION)
  • FIGURE 6. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 7. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, 2019-2027 (USD BILLION)
  • FIGURE 8. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 9. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2019-2027 (USD BILLION)
  • FIGURE 10. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 11. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2019-2027 (USD BILLION)
  • FIGURE 12. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 13. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2019-2027 (USD BILLION)
  • FIGURE 14. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 15. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, 2019-2027 (USD BILLION)
  • FIGURE 16. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 17. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, 2019-2027 (USD BILLION)
  • FIGURE 18. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 19. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, 2019-2027 (USD BILLION)
  • FIGURE 20. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 21. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2019-2027 (USD BILLION)
  • FIGURE 22. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 23. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2019-2027 (USD BILLION)
  • FIGURE 24. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 25. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, 2019-2027 (USD BILLION)
  • FIGURE 26. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 27. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, 2019-2027 (USD BILLION)
  • FIGURE 28. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 29. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, 2019-2027 (USD BILLION)
  • FIGURE 30. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 31. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS VECTORS, 2019-2027 (USD BILLION)
  • FIGURE 32. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS VECTORS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 33. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY RETROVIRAL VECTORS, 2019-2027 (USD BILLION)
  • FIGURE 34. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 35. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, 2019-2027 (USD BILLION)
  • FIGURE 36. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 37. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NON-VIRAL VECTOR, 2019-2027 (USD BILLION)
  • FIGURE 38. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 39. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, 2019-2027 (USD BILLION)
  • FIGURE 40. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 41. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
  • FIGURE 42. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD BILLION)
  • FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2027
  • FIGURE 44. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 45. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 46. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, 2019-2027 (USD BILLION)
  • FIGURE 47. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 48. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 49. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 50. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 51. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 52. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OPHTHALMOLOGY DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 53. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OPHTHALMOLOGY DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 54. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ORTHOPEDIC DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 55. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 56. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
  • FIGURE 57. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
  • FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2027
  • FIGURE 59. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, 2019-2027 (USD BILLION)
  • FIGURE 60. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 61. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2019-2027 (USD BILLION)
  • FIGURE 62. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 63. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
  • FIGURE 64. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (USD BILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2027
  • FIGURE 66. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (USD BILLION)
  • FIGURE 67. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 68. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD BILLION)
  • FIGURE 69. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 70. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 71. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 72. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 73. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 74. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 75. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 76. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 77. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 78. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 79. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 80. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 81. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 82. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 83. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 84. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 85. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 86. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 87. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 88. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 89. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 90. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 91. ITALY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 92. NETHERLANDS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 93. QATAR CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 94. RUSSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 95. SAUDI ARABIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 96. SOUTH AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 97. SPAIN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 98. UNITED ARAB EMIRATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 99. UNITED KINGDOM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 100. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 101. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 102. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
  • TABLE 4. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 5. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 6. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 7. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 9. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 10. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 11. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 12. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ALLOGENEIC, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 14. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 15. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 16. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 17. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 18. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 19. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 20. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 21. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 22. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 23. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 24. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 25. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 26. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 27. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 28. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 29. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 30. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 31. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 32. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 33. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 34. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 35. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 36. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 37. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 38. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 39. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 40. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 41. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 42. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 43. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY AUTOLOGOUS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 44. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 45. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 46. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 47. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 48. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 49. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 50. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 51. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 52. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 54. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 55. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 56. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 57. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NATURAL KILLER CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 59. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 60. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 61. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 62. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY T-CELLS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 64. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 65. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 66. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 67. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY VIRAL VECTOR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 69. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS VECTORS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 70. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS VECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 71. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS VECTORS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 72. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS VECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS VECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 74. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 75. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY RETROVIRAL VECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 76. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY RETROVIRAL VECTORS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 77. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY RETROVIRAL VECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY RETROVIRAL VECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 79. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 80. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 81. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 82. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 84. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 85. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NON-VIRAL VECTOR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 86. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NON-VIRAL VECTOR, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 87. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NON-VIRAL VECTOR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY NON-VIRAL VECTOR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 89. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 90. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 91. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 92. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 94. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
  • TABLE 95. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 96. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 97. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 98. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 100. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 101. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 102. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 103. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 105. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 106. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 107. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 108. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 110. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 111. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 112. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 113. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 115. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OPHTHALMOLOGY DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 116. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OPHTHALMOLOGY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 117. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OPHTHALMOLOGY DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 118. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OPHTHALMOLOGY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY OPHTHALMOLOGY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 120. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 121. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 122. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 123. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 125. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 126. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 127. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 128. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 129. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 131. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 132. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 133. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 134. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 136. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY END-USER, 2019-2027 (USD BILLION)
  • TABLE 137. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 138. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 139. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 140. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 142. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 143. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 144. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 145. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 147. AMERICAS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 148. ARGENTINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 149. BRAZIL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 150. CANADA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 151. MEXICO CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 152. UNITED STATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 153. ASIA-PACIFIC CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 154. AUSTRALIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 155. CHINA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 156. INDIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 157. INDONESIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 158. JAPAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 159. MALAYSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 160. PHILIPPINES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 161. SINGAPORE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 162. SOUTH KOREA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 163. TAIWAN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 164. THAILAND CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 166. FRANCE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 167. GERMANY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 168. ITALY CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 169. NETHERLANDS CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 170. QATAR CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 171. RUSSIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 172. SAUDI ARABIA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 173. SOUTH AFRICA CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 174. SPAIN CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 175. UNITED ARAB EMIRATES CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 176. UNITED KINGDOM CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 177. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: SCORES
  • TABLE 178. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: BUSINESS STRATEGY
  • TABLE 179. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: PRODUCT SATISFACTION
  • TABLE 180. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: RANKING
  • TABLE 181. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 182. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: MERGER & ACQUISITION
  • TABLE 183. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 184. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 185. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: INVESTMENT & FUNDING
  • TABLE 186. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 187. GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!